NAV

Elcatonin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Elcatonin
Accession Number
DB13742
Description
Not Available
Type
Small Molecule
Groups
Experimental
Synonyms
  • Elcatonina

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Unlock Additional Data
AcalabrutinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Acalabrutinib.
AcebutololThe risk or severity of adverse effects can be increased when Acebutolol is combined with Elcatonin.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Elcatonin.
AfatinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Afatinib.
AldesleukinThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin.
AlectinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Alectinib.
Alendronic acidThe risk or severity of hypocalcemia can be increased when Elcatonin is combined with Alendronic acid.
Aminosalicylic acidThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Aminosalicylic acid.
AmitriptylineThe risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptyline.
AmitriptylinoxideThe risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptylinoxide.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Categories

ATC Codes
H05BA04 — Elcatonin
Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
W0CMS474JK
CAS number
60731-46-6
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
Wikipedia
Elcatonin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on June 23, 2017 14:47 / Updated on June 12, 2020 10:53

Drug search 4